公司資料
Alkermes plc 股價、新聞與催化劑
- 股票代碼:
- ALKS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Ireland
股票表現
44.54 USD (-2.94%)
收盤價
最後更新: 2026年11月5日
6.89B USD
市值
股價為何變動
最新公司動態「Alkermes Showcases Research From Psychiatry and Sleep Portfolios at the Neuroscience Education Institute Fall Congress」發布後，ALKS 於 2026年11月5日 收於 $44.54，較前一交易日下跌 2.94%。該變動發生在與這則公司動態對應的交易時段。
公司概覽
業務概覽
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
所在地與產業分類
Alkermes is headquartered in Ireland and listed on NASDAQ. It has a global footprint with a strong U.S. commercial base.
商業模式特徵
The company generates value through product sales, neuroscience development, and lifecycle management across a specialty portfolio. Investors watch commercial execution, pipeline progress, and strategic allocation.
生技產業定位
Alkermes sits in the upper tier of specialty neuroscience biotech. It is more durable than a pure development-stage name, but catalyst events still matter to the story.
未來催化劑
- Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix. Investors will watch whether the commercial base stays durable.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。